The number of annual neonatal abstinence syndrome (NAS)
births in Colorado increased 120% between 2011 and 2016

Within the scope of perinatal care for women and newborns at risk of (or impacted by) substance use, communicating with families in non-stigmatizing and health-promoting ways is vital. Consistency among perinatal providers in their practices around screening, testing, interfacing with other systems, and understanding of the implications of substance use, will ultimately support the health of both mothers and newborns.

Offered in partnership with Illuminate Colorado, this free, eight-week ECHO series will offer Colorado perinatal providers and support personnel in the medical setting best practice approaches for the care of families at risk of and/or impacted by prenatal substance exposure. 

PRENATAL SUBSTANCE EXPOSURE:
PERINATAL CARE FOR WOMEN AND NEWBORNS

 

AUDIENCE:
Perinatal providers (MD, DO, PA, APN), perinatal nurses, social workers and support personnel (RN, social worker, care coordinator)

COMMITMENT:
Eight weekly ECHO sessions held virtually

In Partnership With:

  • ECHO SESSION 1

    SUD in Pregnant and Postpartum Women

  • ECHO SESSION 2

    Patient Communication and Screening for Substance Use

  • ECHO SESSION 3

    Legal Considerations

  • ECHO SESSION 4

    Implications for Neonatal Care

  • ECHO SESSION 5

    Testing and Toxicology

  • ECHO SESSION 6

    Implications for Breastfeeding

  • ECHO SESSION 7

    Interfacing with the Child Welfare System

  • ECHO SESSION 8

    Plans for Safe Care

Other Current and Upcoming ECHO Series
We are always expanding our ECHO series topics. Click here for email notifications of future ECHO series.